You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINDAMYCIN PHOSPHATE AND TRETINOIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Clindamycin Phosphate And Tretinoin patents expire, and when can generic versions of Clindamycin Phosphate And Tretinoin launch?

Clindamycin Phosphate And Tretinoin is a drug marketed by Actavis Mid Atlantic, Encube, and Solaris Pharma Corp. and is included in three NDAs.

The generic ingredient in CLINDAMYCIN PHOSPHATE AND TRETINOIN is clindamycin phosphate; tretinoin. There are fifty-five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the clindamycin phosphate; tretinoin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Clindamycin Phosphate And Tretinoin

A generic version of CLINDAMYCIN PHOSPHATE AND TRETINOIN was approved as clindamycin phosphate; tretinoin by ACTAVIS MID ATLANTIC on June 12th, 2015.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CLINDAMYCIN PHOSPHATE AND TRETINOIN?
  • What are the global sales for CLINDAMYCIN PHOSPHATE AND TRETINOIN?
  • What is Average Wholesale Price for CLINDAMYCIN PHOSPHATE AND TRETINOIN?
Summary for CLINDAMYCIN PHOSPHATE AND TRETINOIN
Drug patent expirations by year for CLINDAMYCIN PHOSPHATE AND TRETINOIN
Recent Clinical Trials for CLINDAMYCIN PHOSPHATE AND TRETINOIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Alphacait, LLCPhase 2
Haining Health-Coming Biotech Co., Ltd.Phase 2
Zeichner, Joshua, M.D.Phase 4

See all CLINDAMYCIN PHOSPHATE AND TRETINOIN clinical trials

Pharmacology for CLINDAMYCIN PHOSPHATE AND TRETINOIN

US Patents and Regulatory Information for CLINDAMYCIN PHOSPHATE AND TRETINOIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic CLINDAMYCIN PHOSPHATE AND TRETINOIN clindamycin phosphate; tretinoin GEL;TOPICAL 202564-001 Jun 12, 2015 AB1 RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Encube CLINDAMYCIN PHOSPHATE AND TRETINOIN clindamycin phosphate; tretinoin GEL;TOPICAL 216943-001 Sep 1, 2023 AB2 RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Solaris Pharma Corp CLINDAMYCIN PHOSPHATE AND TRETINOIN clindamycin phosphate; tretinoin GEL;TOPICAL 212845-001 Feb 10, 2022 AB2 RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.